Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?

Paola TorresFiorella CañeteLaura NúñezAriadna AguilarFrancisco MesoneroMargalida CalafatCristina FernándezAïna TenienteMíriam MañosaAntonio López-SanrománEugeni Domènech

Published in: Digestive diseases and sciences (2019)

Anti-TNF administration at longer intervals than those provided in the data sheet may be an efficacious, convenient, and cheaper treatment option, particularly in patients in whom anti-TNF treatment was initiated early.

Keyphrases

rheumatoid arthritis
end stage renal disease
patients with inflammatory bowel disease
newly diagnosed
ejection fraction
peritoneal dialysis
machine learning
electronic health record
combination therapy
patient reported outcomes
patient reported